Trials / Completed
CompletedNCT00611442
Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy
Single Dose Lubiprostone Along With Split-dose PEG Solution Without Dietary Restrictions for Bowel Cleansing Prior to Colonoscopy, a Randomized, Double-blind, Placebo Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 191 (actual)
- Sponsor
- Brooke Army Medical Center · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The primary outcomes of this procedure will be: 1. The cleanliness of the prep as measured by the Ottawa Scale (attachment a). Secondary outcomes will be: 1. Patient satisfaction with the prep measured by 5 point Likert scale (attachment b); 2. Procedure time; 3. The number and size of polyps detected on examination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lubiprostone | lubiprostone 24mcg gelcap, 1 gelcap taken at noon the day prior to the colonoscopy |
| DRUG | placebo | placebo gelcap, taken at noon the day prior to the colonoscopy |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2008-02-11
- Last updated
- 2012-11-01
- Results posted
- 2012-11-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00611442. Inclusion in this directory is not an endorsement.